Financials HNO

Equities

HNOI

US4047291053

Market Closed - OTC Markets 12:33:52 01/06/2024 am IST 5-day change 1st Jan Change
1.16 USD +0.87% Intraday chart for HNO -0.85% -.--%

Valuation

Fiscal Period: October 2021 2022 2023
Capitalization 1 1.166 191.6 482.2
Enterprise Value (EV) 1 1.203 192.7 483.4
P/E ratio -3,068 x -170 x -281 x
Yield - - -
Capitalization / Revenue - 5,56,11,85,602 x 37,09,56,01,615 x
EV / Revenue - 5,59,48,25,399 x 37,18,32,81,692 x
EV / EBITDA - - -35,10,97,027 x
EV / FCF - - -30,21,56,466 x
FCF Yield - - -0%
Price to Book -8,318 x -172 x -4,733 x
Nbr of stocks (in thousands) 265 1,05,265 4,19,342
Reference price 2 4.400 1.820 1.150
Announcement Date 22/03/23 22/03/23 29/01/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: October 2021 2022 2023
Net sales - 0.0344 0.013
EBITDA - - -1.377
EBIT 1 -0.1329 -1.057 -1.417
Operating Margin - -3,067.22% -10,899.18%
Earnings before Tax (EBT) 1 -0.1329 -1.071 -1.441
Net income 1 -0.1329 -1.071 -1.441
Net margin - -3,109.75% -11,087.19%
EPS 2 -0.001434 -0.0107 -0.004089
Free Cash Flow - - -1.6
FCF margin - - -12,305.97%
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 22/03/23 22/03/23 29/01/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: October 2021 2022 2023
Net Debt 1 0.04 1.16 1.14
Net Cash position 1 - - -
Leverage (Debt/EBITDA) - - -0.8279 x
Free Cash Flow - - -1.6
ROE (net income / shareholders' equity) - 186% 240%
ROA (Net income/ Total Assets) - - -122%
Assets 1 - - 1.186
Book Value Per Share 2 -0 -0.0100 -0
Cash Flow per Share - 0 0
Capex - - 0.8
Capex / Sales - - 6,191.37%
Announcement Date 22/03/23 22/03/23 29/01/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA